In 2011, the total Asia-Pacific market for cardiac surgery devices was valued at over $333 million, an
increase of 3.8% from the previous year. The Asia-Pacific region encompasses Japan, Australia and South Korea. These markets for cardiac
surgery devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, onpump
coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices,
endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), cardiac ablation devices,
ventricular assist devices (VADs), intra-aortic balloon pumps, artificial heart replacement devices, patent
foramen ovale (PFO) devices and atrial and ventricular septal defect devices. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.Top Companies Covered: Medtronic, St. Jude, WL Gore. We provide a detailed analysis of the competative landscape including market shares and qualitative discussions of the leading and upcoming competitors in each market segment. Identify Strategic Opportunities, Customer Feedback and Market Monitoring, Market Overview by Segment & Country, Trend Analysis by Segment & Country, Mergers & Acqusitions.